A soybean peptide isolate diet promotes postprandial carbohydrate oxidation and energy expenditure in type II diabetic mice.
The aim of the present study was to determine the effects of dietary proteins on the oxidation of dietary carbohydrate and lipids in type II diabetic mice. KK-A(y) strain mice were provided free access to a high fat diet (30% of energy as fat) for an initial 4-wk period to induce diabetes. To reduce body weight gain, the mice were subsequently fed restrictive isoenergetic and isonitrogenous diets (35% of energy as protein and 5% as fat) based on either casein or soy protein isolate hydrolysate (SPI-H) for 4 wk. To measure exogenous carbohydrate and lipid oxidation, the mice were fed a diet containing (13)C-glucose or (13)C-triolein while they were in a respiratory chamber for 72 h. Postprandial energy expenditure was higher in the SPI-H than in the casein group; this difference was due to an increase in postprandial exogenous and endogenous carbohydrate oxidation. There were no differences in 24-h energy expenditure between dietary groups. Oxidation of exogenous carbohydrate tended to be higher (P = 0.054) in the SPI-H group during the 24 h of measurement. Fecal excretion of (13)C-glucose was lower but the excretion of lipid was higher in mice fed the SPI-H diet than in casein-fed mice. These results indicate that in type II diabetic mice, dietary SPI-H not only inhibits the absorption of dietary lipids and increases the absorption of dietary carbohydrates but also augments postprandial energy expenditure, which is accompanied by a postprandial increase in oxidation of dietary carbohydrates.
Ishihara
Kengo
K
Department of Food and Nutrition, School of Life Studies, Sugiyama Jogakuen University, Nagoya 464-8662, Japan. kengo@food.sugiyama-u.ac.jp
Oyaizu
Shinichi
S
Fukuchi
Yoshiko
Y
Mizunoya
Wataru
W
Segawa
Kikumi
K
Takahashi
Miki
M
Mita
Yukiko
Y
Fukuya
Yoko
Y
Fushiki
Tohru
T
Yasumoto
Kyoden
K
D000818:Animals; D001835:Body Weight; D002247:Carbon Isotopes / Q000378:metabolism; D002364:Caseins / Q000008:administration & dosage; D003924:Diabetes Mellitus, Type 2 / Q000378:metabolism*; D004040:Dietary Carbohydrates / Q000378:metabolism* / Q000493:pharmacokinetics; D004041:Dietary Fats / Q000378:metabolism / Q000493:pharmacokinetics; D004044:Dietary Proteins / Q000008:administration & dosage*; D002149:Energy Intake; D004734:Energy Metabolism; D005243:Feces / Q000737:chemistry; D007408:Intestinal Absorption; D008297:Male; D051379:Mice; D010084:Oxidation-Reduction; D030262:Soybean Proteins / Q000008:administration & dosage*; D014304:Triolein / Q000008:administration & dosage / Q000378:metabolism / Q000493:pharmacokinetics
D002247:Carbon Isotopes; D002364:Caseins; D004040:Dietary Carbohydrates; D004041:Dietary Fats; D004044:Dietary Proteins; D030262:Soybean Proteins; D014304:Triolein